scholarly journals The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease

2011 ◽  
Vol 104 (5) ◽  
pp. 458-465 ◽  
Author(s):  
Shuko Harada ◽  
Rosemarie Mick ◽  
Robert E. Roses ◽  
Holly Graves ◽  
Huilin Niu ◽  
...  
Keyword(s):  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Invasive Disease ◽  
Her 2

Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER-2 overexpression

2007 ◽  
Vol 68 (1) ◽  
pp. 235 ◽  
Author(s):  
Kadri Altundag ◽  
Mehmet E Tezcan ◽  
Mehmet Ozen ◽  
Fatih Karaahmet ◽  
Nilufer Bulut
Keyword(s):  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Trastuzumab Treatment ◽  
Her 2

Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study

2008 ◽  
Vol 14 (14) ◽  
pp. 4446-4454 ◽  
Author(s):  
Vladimir V. Iakovlev ◽  
Nona C.R. Arneson ◽  
Vietty Wong ◽  
Chunjie Wang ◽  
Stephanie Leung ◽  
...  
Keyword(s):  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Invasive Disease

C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu

2006 ◽  
Vol 37 (2) ◽  
pp. 205-211 ◽  
Author(s):  
Raihanatou Diallo ◽  
Achim Rody ◽  
Christian Jackisch ◽  
Evelyn Ting ◽  
Karl-Ludwig Schaefer ◽  
...  
Keyword(s):  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Her 2
Sign in / Sign up

Export Citation Format

Share Document